Publikationen 2007
1: Gallina A, Briganti A, Chun FK, Walz J, Hutterer GC, Erbersdobler A,
Eichelberg C, Schlomm T, Ahyai SA, Perrotte P, Saad F, Montorsi F, Huland H,
Graefen M, Karakiewicz PI.
Effect of autologous blood transfusion on the rate of biochemical recurrence
after radical prostatectomy.
BJU Int. 2007 Dec;100(6):1249-53. Epub 2007 Sep 10.
PMID: 17850374 [PubMed - indexed for MEDLINE]
2: Briganti A, Chun FK, Suardi N, Gallina A, Walz J, Graefen M, Shariat S,
Ebersdobler A, Rigatti P, Perrotte P, Saad F, Montorsi F, Huland H, Karakiewicz
PI.
Prostate volume and adverse prostate cancer features: fact not artifact.
Eur J Cancer. 2007 Dec;43(18):2669-77. Epub 2007 Nov 8.
PMID: 17996442 [PubMed - indexed for MEDLINE]
3: Schlomm T, Kirstein P, Iwers L, Daniel B, Steuber T, Walz J, Chun FH, Haese A,
Kollermann J, Graefen M, Huland H, Sauter G, Simon R, Erbersdobler A.
Clinical significance of epidermal growth factor receptor protein overexpression
and gene copy number gains in prostate cancer.
Clin Cancer Res. 2007 Nov 15;13(22 Pt 1):6579-84.
PMID: 18006757 [PubMed - indexed for MEDLINE]
4: Loppow D, Huland E, Heinzer H, Grönke L, Magnussen H, Holz O, Jörres RA.
Interleukin-2 inhalation therapy temporarily induces asthma-like airway
inflammation.
Eur J Med Res. 2007 Nov 5;12(11):556-62.
PMID: 18024264 [PubMed - indexed for MEDLINE]
5: Graefen M.
Is the open retropubic radical prostatectomy dead?
Eur Urol. 2007 Nov;52(5):1281-3. Epub 2007 Aug 22. No abstract available.
PMID: 17764828 [PubMed - indexed for MEDLINE]
6: Gallina A, Jeldres C, Chun FK, Shariat SF, Briganti A, Walz J, Roehrborn CG,
Saad F, Huland H, Graefen M, Montorsi F, Karakiewicz PI.
Prediction of pathological stage is inaccurate in men with PSA values above 20
ng/mL.
Eur Urol. 2007 Nov;52(5):1374-80. Epub 2006 Dec 11.
PMID: 17174466 [PubMed - indexed for MEDLINE]
7: Chun FK, Briganti A, Gallina A, Hutterer GC, Shariat SF, Antebie E, Walz J,
Roehrborn CG, Salonia A, Rigatti P, Saad F, Huland H, Montorsi F, Graefen M,
Karakiewicz PI.
Prostate-specific antigen improves the ability of clinical stage and biopsy
Gleason sum to predict the pathologic stage at radical prostatectomy in the new
millennium.
Eur Urol. 2007 Oct;52(4):1067-74. Epub 2007 Mar 20.
PMID: 17383807 [PubMed - indexed for MEDLINE]
8: Friedrich MG, Pichlmeier U, Schwaibold H, Conrad S, Huland H.
Long-term intravesical adjuvant chemotherapy further reduces recurrence rate
compared with short-term intravesical chemotherapy and short-term therapy with
Bacillus Calmette-Guérin (BCG) in patients with non-muscle-invasive bladder
carcinoma.
Eur Urol. 2007 Oct;52(4):1123-29. Epub 2007 Mar 12.
PMID: 17383080 [PubMed - indexed for MEDLINE]
9: Briganti A, Chun FK, Hutterer GC, Gallina A, Shariat SF, Salonia A, Scattoni
V, Valiquette L, Montorsi F, Rigatti P, Graefen M, Huland H, Karakiewicz PI.
Systematic assessment of the ability of the number and percentage of positive
biopsy cores to predict pathologic stage and biochemical recurrence after radical
prostatectomy.
Eur Urol. 2007 Sep;52(3):733-43. Epub 2007 Mar 6.
PMID: 17350750 [PubMed - indexed for MEDLINE]
10: Walz J, Gallina A, Hutterer G, Perrotte P, Shariat SF, Graefen M, McCormack
M, Bénard F, Valiquette L, Saad F, Karakiewicz PI.
Accuracy of life tables in predicting overall survival in candidates for
radiotherapy for prostate cancer.
Int J Radiat Oncol Biol Phys. 2007 Sep 1;69(1):88-94. Epub 2007 Apr 18.
PMID: 17446004 [PubMed - indexed for MEDLINE]
11: Schlomm T, Sültmann H, Poustka A, Sauter G, Hellwinkel OJ, Huland H.
[Molecular high throughput research in prostate carcinoma]
Urologe A. 2007 Sep;46(9):1097-100. German. No abstract available.
PMID: 17628772 [PubMed - indexed for MEDLINE]
12: Walz J, Gallina A, Saad F, Montorsi F, Perrotte P, Shariat SF, Jeldres C,
Graefen M, Bénard F, McCormack M, Valiquette L, Karakiewicz PI.
A nomogram predicting 10-year life expectancy in candidates for radical
prostatectomy or radiotherapy for prostate cancer.
J Clin Oncol. 2007 Aug 20;25(24):3576-81.
PMID: 17704404 [PubMed - indexed for MEDLINE]
13: Gallina A, Karakiewicz PI, Hutterer GC, Chun FK, Briganti A, Walz J, Antebi
E, Shariat SF, Suardi N, Graefen M, Erbersdobler A, Salonia A, Rigatti P, Huland
H, Montorsi F.
Obesity does not predispose to more aggressive prostate cancer either at biopsy
or radical prostatectomy in European men.
Int J Cancer. 2007 Aug 15;121(4):791-5.
PMID: 17455251 [PubMed - indexed for MEDLINE]
14: Chun FK, Briganti A, Graefen M, Montorsi F, Porter C, Scattoni V, Gallina A,
Walz J, Haese A, Steuber T, Erbersdobler A, Schlomm T, Ahyai SA, Currlin E,
Valiquette L, Heinzer H, Rigatti P, Huland H, Karakiewicz PI.
Development and external validation of an extended 10-core biopsy nomogram.
Eur Urol. 2007 Aug;52(2):436-44. Epub 2006 Sep 11.
PMID: 17010505 [PubMed - indexed for MEDLINE]
15: Gallina A, Chun FK, Briganti A, Shariat SF, Montorsi F, Salonia A,
Erbersdobler A, Rigatti P, Valiquette L, Huland H, Graefen M, Karakiewicz PI.
Development and split-sample validation of a nomogram predicting the probability
of seminal vesicle invasion at radical prostatectomy.
Eur Urol. 2007 Jul;52(1):98-105. Epub 2007 Jan 22.
PMID: 17267098 [PubMed - indexed for MEDLINE]
16: Rades D, Schwarz R, Todorovic M, Thurmann H, Graefen M, Walz J, Schild SE,
Dunst J, Alberti W.
Experiences with a new high-dose-rate brachytherapy (HDR-BT) boost technique for
T3b prostate cancer.
Strahlenther Onkol. 2007 Jul;183(7):398-402.
PMID: 17609874 [PubMed - indexed for MEDLINE]
17: Friedrich MG, Toma MI, Chun JK, Steuber T, Budäus L, Isbarn H, Huland H.
[DNA methylation on urinalysis and as a prognostic marker in urothelial cancer of
the bladder]
Urologe A. 2007 Jul;46(7):761-8. German.
PMID: 17522834 [PubMed - indexed for MEDLINE]
18: Gallina A, Karakiewicz PI, Chun FK, Briganti A, Graefen M, Montorsi F, Walz
J, Jeldres C, Erbersdobler A, Salonia A, Suardi N, Dehò F, Schlomm T, Scattoni V,
Haese A, Heinzer H, Valiquette L, Rigatti P, Huland H.
Health-insurance status is a determinant of the stage at presentation and of
cancer control in European men treated with radical prostatectomy for clinically
localized prostate cancer.
BJU Int. 2007 Jun;99(6):1404-8. Epub 2007 Apr 8.
PMID: 17428250 [PubMed - indexed for MEDLINE]
19: Briganti A, Karakiewicz PI, Chun FK, Gallina A, Salonia A, Zanni G,
Valiquette L, Graefen M, Huland H, Rigatti P, Montorsi F.
Percentage of positive biopsy cores can improve the ability to predict lymph node
invasion in patients undergoing radical prostatectomy and extended pelvic lymph
node dissection.
Eur Urol. 2007 Jun;51(6):1573-81. Epub 2007 Feb 6.
PMID: 17293026 [PubMed - indexed for MEDLINE]
20: Kotzerke J, Zöphel K, Salomon G, Graefen M, Heidenreich A.
[Pro and contra: 11C choline PET in diagnosis of prostate cancer]
Aktuelle Urol. 2007 May;38(3):189-94. German. No abstract available.
PMID: 17566231 [PubMed - indexed for MEDLINE]
21: Hutterer G, Perrotte P, Gallina A, Walz J, Jeldres C, Traumann M, Suardi N,
Saad F, Bénard F, Valiquette L, McCormack M, Graefen M, Montorsi F, Karakiewicz
PI.
Body mass index does not predict prostate-specific antigen or percent free
prostate-specific antigen in men undergoing prostate cancer screening.
Eur J Cancer. 2007 May;43(7):1180-7. Epub 2007 Feb 9.
PMID: 17292604 [PubMed - indexed for MEDLINE]
22: Chun FK, Graefen M, Briganti A, Gallina A, Hopp J, Kattan MW, Huland H,
Karakiewicz PI.
Initial biopsy outcome prediction--head-to-head comparison of a logistic
regression-based nomogram versus artificial neural network.
Eur Urol. 2007 May;51(5):1236-40; discussion 1241-3. Epub 2006 Aug 4.
PMID: 16945477 [PubMed - indexed for MEDLINE]
23: Chun FK, Karakiewicz PI, Briganti A, Walz J, Kattan MW, Huland H, Graefen M.
A critical appraisal of logistic regression-based nomograms, artificial neural
networks, classification and regression-tree models, look-up tables and
risk-group stratification models for prostate cancer.
BJU Int. 2007 Apr;99(4):794-800.
PMID: 17378842 [PubMed - indexed for MEDLINE]
24: Chun FK, Briganti A, Jeldres C, Erbersdobler A, Schlomm T, Steuber T, Gallina
A, Walz J, Perrotte P, Huland H, Graefen M, Karakiewicz PI.
Zonal origin of localized prostate cancer does not affect the rate of biochemical
recurrence after radical prostatectomy.
Eur Urol. 2007 Apr;51(4):949-55; discussion 955. Epub 2006 Jul 28.
PMID: 16904818 [PubMed - indexed for MEDLINE]
25: Schwarzenbach H, Chun FK, Lange I, Carpenter S, Gottberg M, Erbersdobler A,
Friedrich MG, Huland H, Pantel K.
Detection of tumor-specific DNA in blood and bone marrow plasma from patients
with prostate cancer.
Int J Cancer. 2007 Apr 1;120(7):1465-71.
PMID: 17205532 [PubMed - indexed for MEDLINE]
26: Steuber T, Vickers A, Haese A, Kattan MW, Eastham JA, Scardino PT, Huland H,
Lilja H.
Free PSA isoforms and intact and cleaved forms of urokinase plasminogen activator
receptor in serum improve selection of patients for prostate cancer biopsy.
Int J Cancer. 2007 Apr 1;120(7):1499-504.
PMID: 17205511 [PubMed - indexed for MEDLINE]
27: Briganti A, Salonia A, Gallina A, Chun FK, Karakiewicz PI, Graefen M, Huland
H, Rigatti P, Montorsi F.
Management of erectile dysfunction after radical prostatectomy in 2007.
World J Urol. 2007 Apr;25(2):143-8. Epub 2007 Mar 6. Review.
PMID: 17340159 [PubMed - indexed for MEDLINE]
28: Chun FK, Karakiewicz PI, Huland H, Graefen M.
Role of nomograms for prostate cancer in 2007.
World J Urol. 2007 Apr;25(2):131-42. Epub 2007 Feb 27. Review.
PMID: 17333203 [PubMed - indexed for MEDLINE]
29: Schwarz R, Graefen M, Krüll A.
Therapy of recurrent disease after radical prostatectomy in 2007.
World J Urol. 2007 Apr;25(2):161-7. Epub 2007 Feb 28. Review.
PMID: 17333202 [PubMed - indexed for MEDLINE]
30: Burchardt M, Huland H.
Treatment of localized prostate cancer.
World J Urol. 2007 Mar;25(1):1-2. No abstract available.
PMID: 17342489 [PubMed - indexed for MEDLINE]
31: Stephan C, Xu C, Cammann H, Graefen M, Haese A, Huland H, Semjonow A,
Diamandis EP, Remzi M, Djavan B, Wildhagen MF, Blijenberg BG, Finne P, Stenman
UH, Jung K, Meyer HA.
Assay-specific artificial neural networks for five different PSA assays and
populations with PSA 2-10 ng/ml in 4,480 men.
World J Urol. 2007 Mar;25(1):95-103. Epub 2007 Feb 28.
PMID: 17333205 [PubMed - indexed for MEDLINE]
32: Walz J, Graefen M, Huland H.
Basic principles of anatomy for optimal surgical treatment of prostate cancer.
World J Urol. 2007 Mar;25(1):31-8. Epub 2007 Feb 27. Review.
PMID: 17333199 [PubMed - indexed for MEDLINE]
33: Walz J, Graefen M, Michl UH, Heinzer H, Friedrich MG, Eichelberg C, Haese A,
Huland H.
Technical aspects of nerve sparing during retropubic prostatectomy
Ann Urol (Paris). 2007 Feb;41(1):23-30. French.
PMID: 17338497 [PubMed - indexed for MEDLINE]
34: Steuber T, Vickers AJ, Serio AM, Vaisanen V, Haese A, Pettersson K, Eastham
JA, Scardino PT, Huland H, Lilja H.
Comparison of free and total forms of serum human kallikrein 2 and
prostate-specific antigen for prediction of locally advanced and recurrent
prostate cancer.
Clin Chem. 2007 Feb;53(2):233-40. Epub 2006 Dec 21.
PMID: 17185368 [PubMed - indexed for MEDLINE]
35: Chun FK, Briganti A, Jeldres C, Gallina A, Erbersdobler A, Schlomm T, Walz J,
Eichelberg C, Salomon G, Haese A, Currlin E, Ahyai SA, Bénard F, Huland H,
Graefen M, Karakiewicz PI.
Tumour volume and high grade tumour volume are the best predictors of pathologic
stage and biochemical recurrence after radical prostatectomy.
Eur J Cancer. 2007 Feb;43(3):536-43. Epub 2007 Jan 11.
PMID: 17222546 [PubMed - indexed for MEDLINE]
36: Chun FK, Briganti A, Graefen M, Porter C, Montorsi F, Haese A, Scattoni V,
Borden L, Steuber T, Salonia A, Schlomm T, Latchemsetty K, Walz J, Kim J,
Eichelberg C, Currlin E, Ahyai SA, Erbersdobler A, Valiquette L, Heinzer H,
Rigatti P, Huland H, Karakiewicz PI.
Development and external validation of an extended repeat biopsy nomogram.
J Urol. 2007 Feb;177(2):510-5.
PMID: 17222622 [PubMed - indexed for MEDLINE]
37: Aalamian-Matheis M, Chatta GS, Shurin MR, Huland E, Huland H, Shurin GV.
Inhibition of dendritic cell generation and function by serum from prostate
cancer patients: correlation with serum-free PSA.
Adv Exp Med Biol. 2007;601:173-82.
PMID: 17713004 [PubMed - indexed for MEDLINE]
38: Chun FK, Briganti A, Graefen M, Erbersdobler A, Walz J, Schlomm T, Meschke M,
Haese A, Valiquette L, Huland H, Karakiewicz PI.
Body mass index does not improve the ability to predict biochemical recurrence
after radical prostatectomy.
Eur J Cancer. 2007 Jan;43(2):375-82. Epub 2006 Dec 1.
PMID: 17141497 [PubMed - indexed for MEDLINE]
39: Eichelberg C, Erbersdobler A, Michl U, Schlomm T, Salomon G, Graefen M,
Huland H.
Nerve distribution along the prostatic capsule.
Eur Urol. 2007 Jan;51(1):105-10; discussion 110-1. Epub 2006 Jun 12.
© Universitätsklinikum Hamburg-Eppendorf,
ImpressumLetzte Änderung:
, 21.12.2008
